Advertisement
New Zealand markets closed

  • NZX 50

    11,946.43
    +143.15 (+1.21%)
     

  • NZD/USD

    0.5961
    +0.0024 (+0.40%)
     

  • NZD/EUR

    0.5555
    +0.0009 (+0.16%)
     

  • ALL ORDS

    7,937.50
    -0.40 (-0.01%)
     

  • ASX 200

    7,683.00
    -0.50 (-0.01%)
     

  • OIL

    82.93
    +0.12 (+0.14%)
     

  • GOLD

    2,338.00
    -0.40 (-0.02%)
     

  • NASDAQ

    17,526.80
    +55.33 (+0.32%)
     

  • FTSE

    8,094.07
    +53.69 (+0.67%)
     

  • Dow Jones

    38,460.92
    -42.77 (-0.11%)
     

  • DAX

    17,976.22
    -112.48 (-0.62%)
     

  • Hang Seng

    17,284.54
    +83.27 (+0.48%)
     

  • NIKKEI 225

    37,628.48
    -831.60 (-2.16%)
     

  • NZD/JPY

    92.6890
    +0.5740 (+0.62%)
     

2 Red Flags and 1 Green Flag For Illumina Stock

Alex Carchidi, The Motley Fool
·4-min read

Its sequencing devices are among the most widely distributed in global hospitals and laboratories of all stripes, and its ongoing years-long efforts to develop new technologies place it at the cutting edge of the field, with few notable competitors anywhere in sight. Illumina is currently facing some serious legal trouble in the E.U. to the point where it constitutes a red flag for its near-term performance. To prepare for the possible fine, Illumina is setting aside $453 million.

Continue reading